{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:35:48Z","timestamp":1794242148415,"version":"4.9.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,10,10]],"date-time":"2015-10-10T00:00:00Z","timestamp":1444435200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00428-015-1858-9","type":"journal-article","created":{"date-parts":[[2015,10,10]],"date-time":"2015-10-10T07:19:03Z","timestamp":1444461543000},"page":"259-275","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":107,"title":["The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing"],"prefix":"10.1007","volume":"468","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3832-3329","authenticated-orcid":false,"given":"Steven H.","family":"Swerdlow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isinsu","family":"Kuzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Dirnhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K. C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Xerri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,10]]},"reference":[{"key":"1858_CR1","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/00000478-200106000-00005","volume":"25","author":"JA Andriko","year":"2001","unstructured":"Andriko JA, Swerdlow SH, Aguilera NI, Abbondanzo SL (2001) Is lymphoplasmacytic lymphoma\/immunocytoma a distinct entity? A clinicopathologic study of 20 cases. Am J Surg Pathol 25:742\u2013751","journal-title":"Am J Surg Pathol"},{"key":"1858_CR2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/his.12160","volume":"63","author":"R Bob","year":"2013","unstructured":"Bob R, Falini B, Marafioti T, Paterson JC, Pileri S, Stein H (2013) Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: an immunoarchitectural and molecular study highlighting the relevance of IRTA1 and T-bet as positive markers. Histopathology 63:482\u2013498. doi: 10.1111\/his.12160","journal-title":"Histopathology"},{"key":"1858_CR3","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/modpathol.2013.106","volume":"26","author":"I Brenner","year":"2013","unstructured":"Brenner I, Roth S, Puppe B, Wobser M, Rosenwald A, Geissinger E (2013) Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression. Mod Pathol 26:1568\u20131576. doi: 10.1038\/modpathol.2013.106","journal-title":"Mod Pathol"},{"key":"1858_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00000478-199901000-00006","volume":"23","author":"E Campo","year":"1999","unstructured":"Campo E, Miquel R, Krenacs L, Sorbara L, Raffeld M, Jaffe ES (1999) Primary nodal marginal zone lymphomas of splenic and MALT type. Am J Surg Pathol 23:59\u201368","journal-title":"Am J Surg Pathol"},{"key":"1858_CR5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/PAS.0b013e31816148ad","volume":"32","author":"W Cheuk","year":"2008","unstructured":"Cheuk W, Yuen HK, Chan AC, Shih LY, Kuo TT, Ma MW, Lo YF, Chan WK, Chan JK (2008) Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol 32:1159\u20131167. doi: 10.1097\/PAS.0b013e31816148ad","journal-title":"Am J Surg Pathol"},{"key":"1858_CR6","first-page":"1177","volume":"29","author":"A Clipson","year":"2015","unstructured":"Clipson A, Wang M, de Leval L, Ashton-Key M, Wotherspoon A, Vassiliou G, Bolli N, Grove C, Moody S, Escudero-Ibarz L, Gundem G, Brugger K, Xue X (2015) KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype. Blood 29:1177\u20131185. doi: 10.1038\/leu.2014.330","journal-title":"Blood"},{"key":"1858_CR7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cancergencyto.2005.04.013","volume":"162","author":"JR Cook","year":"2005","unstructured":"Cook JR, Aguilera NI, Reshmi S, Huang X, Yu Z, Gollin SM, Abbondanzo SL, Swerdlow SH (2005) Deletion 6q is not a characteristic marker of nodal lymphoplasmacytic lymphoma. Cancer Genet Cytogenet 162:85\u201388","journal-title":"Cancer Genet Cytogenet"},{"key":"1858_CR8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1365-2559.2007.02859.x","volume":"51","author":"CL Cooper","year":"2007","unstructured":"Cooper CL, Joshua DE, Lee CS, Eyers AA, Cooper WA (2007) Extranodal plasmablastic lymphoma arising in mantle cell lymphoma. Histopathology 51:856\u2013859. doi: 10.1111\/j.1365-2559.2007.02859.x","journal-title":"Histopathology"},{"key":"1858_CR9","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1182\/blood-2014-03-565135","volume":"124","author":"MA Dimopoulos","year":"2014","unstructured":"Dimopoulos MA, Kastritis E, Owen RG, Kyle RA, Landgren O, Morra E, Leleu X, Garcia-Sanz R, Munshi N, Anderson KC, Terpos E, Ghobrial IM, Morel P, Maloney D, Rummel M, Leblond V, Advani RH, Gertz MA, Kyriakou C, Thomas SK, Barlogie B, Gregory SA, Kimby E, Merlini G, Treon SP (2014) Treatment recommendations for patients with Waldenstrom macroglobulinemia (WM) and related disorders: IWWM-7 consensus. Blood 124:1404\u20131411. doi: 10.1182\/blood-2014-03-565135","journal-title":"Blood"},{"key":"1858_CR10","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1182\/blood-2013-11-539049","volume":"123","author":"A Duckworth","year":"2014","unstructured":"Duckworth A, Glenn M, Slupsky JR, Packham G, Kalakonda N (2014) Variable induction of PRDM1 and differentiation in chronic lymphocytic leukemia is associated with anergy. Blood 123:3277\u20133285. doi: 10.1182\/blood-2013-11-539049","journal-title":"Blood"},{"key":"1858_CR11","first-page":"467","volume":"91","author":"JF Garcia","year":"2006","unstructured":"Garcia JF, Roncador G, Garcia JF, Sanz AI, Maestre L, Lucas E, Montes-Moreno S, Fernandez Victoria R, Martinez-Torrecuadrara JL, Marafioti T, Mason DY, Piris MA (2006) PRDM1\/BLIMP-1 expression in multiple B and T-cell lymphoma. Haematologica 91:467\u2013474","journal-title":"Haematologica"},{"key":"1858_CR12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/PAS.0b013e3181c811ad","volume":"34","author":"JT Geyer","year":"2010","unstructured":"Geyer JT, Ferry JA, Harris NL, Stone JH, Zukerberg LR, Lauwers GY, Pilch BZ, Deshpande V (2010) Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease. Am J Surg Pathol 34:202\u2013210. doi: 10.1097\/PAS.0b013e3181c811ad","journal-title":"Am J Surg Pathol"},{"key":"1858_CR13","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3324\/haematol.2011.042333","volume":"96","author":"SE Gibson","year":"2011","unstructured":"Gibson SE, Swerdlow SH, Ferry JA, Surti U, Dal Cin P, Harris NL, Hasserjian RP (2011) Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. Haematologica 96:1144\u20131152. doi: 10.3324\/haematol.2011.042333","journal-title":"Haematologica"},{"key":"1858_CR14","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3324\/haematol.2010.022277","volume":"95","author":"E Gin\u00e9","year":"2010","unstructured":"Gin\u00e9 E, Martinez A, Villamor N, L\u00f3pez-Guillermo A, Camos M, Martinez D, Esteve J, Calvo X, Munta\u00f1ola A, Abrisqueta P, Rozman M, Rozman C, Bosch F, Campo E, Montserrat E (2010) Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (\u201caccelerated\u201d chronic lymphocytic leukemia) with aggressive clinical behavior. Haematologica 95:1526\u20131533. doi: 10.3324\/haematol.2010.022277","journal-title":"Haematologica"},{"key":"1858_CR15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/modpathol.2009.146","volume":"23","author":"JF Gradowski","year":"2010","unstructured":"Gradowski JF, Jaffe ES, Warnke RA, Pittaluga S, Surti U, Gole LA, Swerdlow SH (2010) Follicular lymphomas with plasmacytic differentiation include two subtypes. Mod Pathol 23:71\u201379. doi: 10.1038\/modpathol.2009.146","journal-title":"Mod Pathol"},{"key":"1858_CR16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/PAS.0b013e318272fe19","volume":"37","author":"KL Grogg","year":"2013","unstructured":"Grogg KL, Aubry MC, Vrana JA, Theis JD, Dogan A (2013) Nodular pulmonary amyloidosis is characterized by localized immunoglobulin deposition and is frequently associated with an indolent B-cell lymphoproliferative disorder. Am J Surg Pathol 37:406\u2013412. doi: 10.1097\/PAS.0b013e318272fe19","journal-title":"Am J Surg Pathol"},{"key":"1858_CR17","volume":"6","author":"A Gutierrez Jr","year":"2011","unstructured":"Gutierrez A Jr, Arendt BK, Tschumper RC, Kay NE, Zent CS, Jelinek DF (2011) Differentiation of chronic lymphocytic leukemia B cells into immunoglobulin secreting cells decreases LEF-1 expression. PLoS One 6, e26056. doi: 10.1371\/journal.pone.0026056","journal-title":"PLoS One"},{"key":"1858_CR18","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.3324\/haematol.2014.108688","volume":"99","author":"F Hamadeh","year":"2014","unstructured":"Hamadeh F, MacNamara S, Bacon CM, Sohani AR, Swerdlow SH, Cook JR (2014) Gamma heavy chain disease lacks the MYD88 L265p mutation associated with lymphoplasmacytic lymphoma. Haematologica 99:e154\u2013e155. doi: 10.3324\/haematol.2014.108688","journal-title":"Haematologica"},{"key":"1858_CR19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/modpathol.2014.120","volume":"28","author":"F Hamadeh","year":"2015","unstructured":"Hamadeh F, MacNamara SP, Aguilera NS, Swerdlow SH, Cook JR (2015) MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma. Mod Pathol 28:564\u2013574. doi: 10.1038\/modpathol.2014.120","journal-title":"Mod Pathol"},{"key":"1858_CR20","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1182\/blood-2013-09-525808","volume":"123","author":"ZR Hunter","year":"2014","unstructured":"Hunter ZR, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Manning RJ, Tripsas C, Patterson CJ, Sheehy P, Treon SP (2014) The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. Blood 123:1637\u20131646. doi: 10.1182\/blood-2013-09-525808","journal-title":"Blood"},{"key":"1858_CR21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ajcp\/111.1.111","volume":"111","author":"JW Hussong","year":"1999","unstructured":"Hussong JW, Perkins SL, Schnitzer B, Hargreaves H, Frizzera G (1999) Extramedullary plasmacytoma. A form of marginal zone cell lymphoma? Am J Clin Pathol 111:111\u2013116","journal-title":"Am J Clin Pathol"},{"key":"1858_CR22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1309\/AJCPEMVXES72DUIF","volume":"140","author":"JM Jaso","year":"2013","unstructured":"Jaso JM, Yin CC, Wang SA, Miranda RN, Jabcuga CE, Chen L, Medeiros LJ (2013) Clinicopathologic features of CD5-positive nodal marginal zone lymphoma. Am J Clin Pathol 140:693\u2013700. doi: 10.1309\/ajcpemvxes72duif","journal-title":"Am J Clin Pathol"},{"key":"1858_CR23","author":"R Kanagal-Shamanna","year":"2015","unstructured":"Kanagal-Shamanna R, Xu-Monette ZY, Miranda RN, Dogan A, Zou D, Luthra R, Weber D, O\u2019Malley DP, Jorgensen JL, Khoury JD, Bueso-Ramos CE, Orlowski RZ, Medeiros JL, Young KH (2015) Crystal-storing histiocytosis: a clinicopathologic study of 13 cases. Histopathology. doi: 10.1111\/his.12768","journal-title":"Histopathology"},{"key":"1858_CR24","author":"MJ Kiel","year":"2012","unstructured":"Kiel MJ, Velusamy T, Betz BL, Zhao L, Weigelin HG, Chiang MY, Huebner-Chan DR, Bailey NG, Yang DT, Bhagat G, Miranda RN, Bahler DW, Medeiros LJ, Lim MS, Elenitoba-Johnson KS (2012) Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J Exp Med. doi: 10.1084\/jem.20120910","journal-title":"J Exp Med"},{"key":"1858_CR25","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1038\/bcj.2013.28","volume":"3","author":"W Kraan","year":"2013","unstructured":"Kraan W, Horlings HM, van Keimpema M, Schilder-Tol EJ, Oud ME, Scheepstra C, Kluin PM, Kersten MJ, Spaargaren M, Pals ST (2013) High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites. Blood Cancer J 3:e139. doi: 10.1038\/bcj.2013.28","journal-title":"Blood Cancer J"},{"key":"1858_CR26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1309\/R01VXG46MFCDVNHL","volume":"120","author":"P Lin","year":"2003","unstructured":"Lin P, Mansoor A, Bueso-Ramos C, Hao S, Lai R, Medeiros LJ (2003) Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinemia. Clinicopathologic features of 12 cases. Am J Clin Pathol 120:246\u2013253","journal-title":"Am J Clin Pathol"},{"key":"1858_CR27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1309\/AJCP8FOIVTB6LBER","volume":"136","author":"P Lin","year":"2011","unstructured":"Lin P, Molina TJ, Cook JR, Swerdlow SH (2011) Lymphoplasmacytic lymphoma and other non-marginal zone lymphomas with plasmacytic differentiation. Am J Clin Pathol 136:195\u2013210. doi: 10.1309\/AJCP8FOIVTB6LBER","journal-title":"Am J Clin Pathol"},{"key":"1858_CR28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1309\/6U88-357U-UKJ5-YPT3","volume":"116","author":"A Mansoor","year":"2001","unstructured":"Mansoor A, Medeiros LJ, Weber DM, Alexanian R, Hayes K, Jones D, Lai R, Glassman A, Bueso-Ramos CE (2001) Cytogenetic findings in lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course. Am J Clin Pathol 116:543\u2013549","journal-title":"Am J Clin Pathol"},{"key":"1858_CR29","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/PAS.0000000000000411","volume":"39","author":"A Martinez-Lopez","year":"2015","unstructured":"Martinez-Lopez A, Curiel-Olmo S, Mollejo M, Cereceda L, Martinez N, Montes-Moreno S, Almaraz C, Revert JB, Piris MA (2015) MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma. Am J Surg Pathol 39:644\u2013651. doi: 10.1097\/pas.0000000000000411","journal-title":"Am J Surg Pathol"},{"key":"1858_CR30","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2013-12-543306","volume":"123","author":"A Martinez-Trillos","year":"2014","unstructured":"Martinez-Trillos A, Pinyol M, Navarro A, Aymerich M, Jares P, Juan M, Rozman M, Colomer D, Delgado J, Gine E, Gonzalez-Diaz M, Hernandez-Rivas JM, Colado E, Rayon C, Payer AR, Terol MJ, Navarro B, Quesada V, Puente XS, Rozman C, Lopez-Otin C, Campo E, Lopez-Guillermo A, Villamor N (2014) Mutations in TLR\/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome. Blood 123:3790\u20133796. doi: 10.1182\/blood-2013-12-543306","journal-title":"Blood"},{"key":"1858_CR31","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2559.2008.02965.x","volume":"52","author":"SH Nam-Cha","year":"2008","unstructured":"Nam-Cha SH, San-Millan B, Mollejo M, Garcia-Cosio M, Garijo G, Gomez M, Warnke RA, Jaffe ES, Piris MA (2008) Light-chain-restricted germinal centres in reactive lymphadenitis: report of eight cases. Histopathology 52:436\u2013444. doi: 10.1111\/j.1365-2559.2008.02965.x","journal-title":"Histopathology"},{"key":"1858_CR32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/cyto.b.20463","volume":"76","author":"H Naushad","year":"2009","unstructured":"Naushad H, Choi WW, Page CJ, Sanger WG, Weisenburger DD, Aoun P (2009) Mantle cell lymphoma with flow cytometric evidence of clonal plasmacytic differentiation: a case report. Cytometry B Clin Cytom 76:218\u2013224. doi: 10.1002\/cyto.b.20463","journal-title":"Cytometry B Clin Cytom"},{"key":"1858_CR33","doi-asserted-by":"crossref","first-page":"13539","DOI":"10.1038\/srep13539","volume":"5","author":"K Ohno","year":"2015","unstructured":"Ohno K, Sato Y, Ohshima K-i, Takata K, Miyata-Takata T, Takeuchi M, Gion Y, Tachibana T, Orita Y, Ito T, Swerdlow SH, Yoshino T (2015) A subset of ocular adnexal marginal zone lymphomas may arise in association with IgG4-related disease. Sci Rep 5:13539. doi: 10.1038\/srep13539","journal-title":"Sci Rep"},{"key":"1858_CR34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5414\/NP300645","volume":"33","author":"BA Orr","year":"2014","unstructured":"Orr BA, Gallia GL, Dogan A, Rodriguez FJ (2014) IgA\/kappa-restricted crystal storing histiocytosis involving the central nervous system characterized by proteomic analysis. Clin Neuropathol 33:23\u201328. doi: 10.5414\/np300645","journal-title":"Clin Neuropathol"},{"key":"1858_CR35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/leu.2013.124","volume":"28","author":"B Paiva","year":"2014","unstructured":"Paiva B, Montes MC, Garcia-Sanz R, Ocio EM, Alonso J, de Las HN, Escalante F, Cuello R, de Coca AG, Galende J, Hernandez J, Sierra M, Martin A, Pardal E, Barez A, Alonso J, Suarez L, Gonzalez-Lopez TJ, Perez JJ, Orfao A, Vidriales MB, San Miguel JF (2014) Multiparameter flow cytometry for the identification of the Waldenstrom\u2019s clone in IgM-MGUS and Waldenstrom\u2019s macroglobulinemia: new criteria for differential diagnosis and risk stratification. Leukemia 28:166\u2013173. doi: 10.1038\/leu.2013.124","journal-title":"Leukemia"},{"key":"1858_CR36","author":"A Pham-Ledard","year":"2014","unstructured":"Pham-Ledard A, Beylot-Barry M, Barbe C, Leduc M, Petrella T, Vergier B, Martinez F, Cappellen D, Merlio JP, Grange F (2014) High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type. JAMA Dermatol. doi: 10.1001\/jamadermatol.2014.821","journal-title":"JAMA Dermatol"},{"key":"1858_CR37","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1182\/blood-2012-06-436329","volume":"121","author":"S Poulain","year":"2013","unstructured":"Poulain S, Roumier C, Decambron A, Renneville A, Herbaux C, Bertrand E, Tricot S, Daudignon A, Galiegue-Zouitina S, Soenen V, Theisen O, Grardel N, Nibourel O, Roche-Lestienne C, Quesnel B, Duthilleul P, Preudhomme C, Leleu X (2013) MYD88 L265P mutation in Waldenstrom macroglobulinemia. Blood 121:4504\u20134511. doi: 10.1182\/blood-2012-06-436329","journal-title":"Blood"},{"key":"1858_CR38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3324\/haematol.2013.091702","volume":"99","author":"U Randen","year":"2014","unstructured":"Randen U, Troen G, Tierens A, Steen C, Warsame A, Beiske K, Tjonnfjord GE, Berentsen S, Delabie J (2014) Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma. Haematologica 99:497\u2013504. doi: 10.3324\/haematol.2013.091702","journal-title":"Haematologica"},{"key":"1858_CR39","doi-asserted-by":"crossref","unstructured":"Ribera-Cortada I, Martinez D, Amador V, Royo C, Navarro A, Be\u00e0 S, Gine E, Leval L, Serrano S, Wotherspoon A, Colomer D, Martinez A, Campo E (2015) Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype. Mod Pathol. doi: 10.1038\/modpathol.2015.99","DOI":"10.1038\/modpathol.2015.99"},{"key":"1858_CR40","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1309\/AJCP0YGM8BLFYHJY","volume":"139","author":"MJ Roberts","year":"2013","unstructured":"Roberts MJ, Chadburn A, Ma S, Hyjek E, Peterson LC (2013) Nuclear protein dysregulation in lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinemia. Am J Clin Pathol 139:210\u2013219. doi: 10.1309\/ajcp0ygm8blfyhjy","journal-title":"Am J Clin Pathol"},{"key":"1858_CR41","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2014-03-564583","volume":"123","author":"AM Roccaro","year":"2014","unstructured":"Roccaro AM, Sacco A, Jimenez C, Maiso P, Moschetta M, Mishima Y, Aljawai Y, Sahin I, Kuhne M, Cardarelli P, Cohen L, San Miguel JF, Garcia-Sanz R, Ghobrial IM (2014) C1013G\/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma. Blood 123:4120\u20134131. doi: 10.1182\/blood-2014-03-564583","journal-title":"Blood"},{"key":"1858_CR42","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/bjh.13303","volume":"169","author":"FG Rosado","year":"2015","unstructured":"Rosado FG, Morice WG, He R, Howard MT, Timm M, McPhail ED (2015) Immunophenotypic features by multiparameter flow cytometry can help distinguish low grade B-cell lymphomas with plasmacytic differentiation from plasma cell proliferative disorders with an unrelated clonal B-cell process. Br J Haematol 169:368\u2013376. doi: 10.1111\/bjh.13303","journal-title":"Br J Haematol"},{"key":"1858_CR43","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.semcancer.2013.04.002","volume":"23","author":"D Rossi","year":"2013","unstructured":"Rossi D, Ciardullo C, Gaidano G (2013) Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies. Semin Cancer Biol 23:422\u2013430. doi: 10.1016\/j.semcancer.2013.04.002","journal-title":"Semin Cancer Biol"},{"key":"1858_CR44","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/01.pas.0000249445.28713.88","volume":"31","author":"A Ruiz","year":"2007","unstructured":"Ruiz A, Reischl U, Swerdlow SH, Hartke M, Streubel B, Procop G, Tubbs RR, Cook JR (2007) Extranodal marginal zone B-cell lymphomas of the ocular adnexa: multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci. Am J Surg Pathol 31:792\u2013802","journal-title":"Am J Surg Pathol"},{"key":"1858_CR45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/17474086.2014.871494","volume":"7","author":"I Sahin","year":"2014","unstructured":"Sahin I, Leblebjian H, Treon SP, Ghobrial IM (2014) Waldenstrom macroglobulinemia: from biology to treatment. Expert Rev Hematol 7:157\u2013168. doi: 10.1586\/17474086.2014.871494","journal-title":"Expert Rev Hematol"},{"key":"1858_CR46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/AJCPZQ1GXBBNG8OG","volume":"132","author":"ME Salama","year":"2009","unstructured":"Salama ME, Lossos IS, Warnke RA, Natkunam Y (2009) Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma. Am J Clin Pathol 132:39\u201349","journal-title":"Am J Clin Pathol"},{"key":"1858_CR47","author":"J Schmidt","year":"2015","unstructured":"Schmidt J, Federmann B, Schindler N, Steinhilber J, Bonzheim I, Fend F, Quintanilla-Martinez L (2015) MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity. Br J Haematol. doi: 10.1111\/bjh.13361","journal-title":"Br J Haematol"},{"key":"1858_CR48","first-page":"194","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Berger F, Pileri SA, Harris NL, Jaffe ES, Stein H (2008) Lymphoplasmacytic lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 194\u2013195"},{"key":"1858_CR49","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon"},{"key":"1858_CR50","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2011.103","volume":"24","author":"B Tandon","year":"2011","unstructured":"Tandon B, Peterson L, Gao J, Nelson B, Ma S, Rosen S, Chen YH (2011) Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia\/small lymphocytic lymphoma in small B-cell lymphomas. Mod Pathol 24:1433\u20131443. doi: 10.1038\/modpathol.2011.103","journal-title":"Mod Pathol"},{"key":"1858_CR51","doi-asserted-by":"crossref","unstructured":"Tandon B, Swerdlow SH, Hasserjian RP, Surti U, Gibson SE (2015) Chronic lymphocytic leukemia\/small lymphocytic lymphoma: another neoplasm related to the B-cell follicle? Leuk Lymphoma:1\u20139. doi: 10.3109\/10428194.2015.1037759","DOI":"10.3109\/10428194.2015.1037759"},{"key":"1858_CR52","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.leu.2404314","volume":"20","author":"C Terre","year":"2006","unstructured":"Terre C, Nguyen-Khac F, Barin C, Mozziconacci MJ, Eclache V, Leonard C, Chapiro E, Farhat H, Bouyon A, Rousselot P, Choquet S, Spentchian M, Dubreuil P, Leblond V, Castaigne S (2006) Trisomy 4, a new chromosomal abnormality in Waldenstrom\u2019s macroglobulinemia: a study of 39 cases. Leukemia 20:1634\u20131636","journal-title":"Leukemia"},{"key":"1858_CR53","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood-2015-01-553974","volume":"126","author":"SP Treon","year":"2015","unstructured":"Treon SP (2015) How I treat Waldenstrom macroglobulinemia. Blood 126:721\u2013732. doi: 10.1182\/blood-2015-01-553974","journal-title":"Blood"},{"key":"1858_CR54","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2014-01-550905","volume":"123","author":"SP Treon","year":"2014","unstructured":"Treon SP, Cao Y, Xu L, Yang G, Liu X, Hunter ZR (2014) Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia. Blood 123:2791\u20132796. doi: 10.1182\/blood-2014-01-550905","journal-title":"Blood"},{"key":"1858_CR55","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1501548","volume":"372","author":"SP Treon","year":"2015","unstructured":"Treon SP, Tripsas CK, Meid K, Warren D, Varma G, Green R, Argyropoulos KV, Yang G, Cao Y, Xu L, Patterson CJ, Rodig S, Zehnder JL, Aster JC, Harris NL, Kanan S, Ghobrial I, Castillo JJ, Laubach JP, Hunter ZR, Salman Z, Li J, Cheng M, Clow F, Graef T, Palomba ML, Advani RH (2015) Ibrutinib in previously treated Waldenstrom\u2019s macroglobulinemia. N Engl J Med 372:1430\u20131440. doi: 10.1056\/NEJMoa1501548","journal-title":"N Engl J Med"},{"key":"1858_CR56","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","volume":"367","author":"SP Treon","year":"2012","unstructured":"Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Sheehy P, Manning RJ, Patterson CJ, Tripsas C, Arcaini L, Pinkus GS, Rodig SJ, Sohani AR, Harris NL, Laramie JM, Skifter DA, Lincoln SE, Hunter ZR (2012) MYD88 L265P somatic mutation in Waldenstrom\u2019s macroglobulinemia. N Engl J Med 367:826\u2013833. doi: 10.1056\/NEJMoa1200710","journal-title":"N Engl J Med"},{"key":"1858_CR57","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1182\/blood-2012-06-438937","volume":"121","author":"MC Vegliante","year":"2013","unstructured":"Vegliante MC, Palomero J, Perez-Galan P, Roue G, Castellano G, Navarro A, Clot G, Moros A, Suarez-Cisneros H, Bea S, Hernandez L, Enjuanes A, Jares P, Villamor N, Colomer D, Martin-Subero JI, Campo E, Amador V (2013) SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma. Blood 121:2175\u20132185. doi: 10.1182\/blood-2012-06-438937","journal-title":"Blood"},{"key":"1858_CR58","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/modpathol.2010.206","volume":"24","author":"G Venkataraman","year":"2011","unstructured":"Venkataraman G, Rizzo KA, Chavez JJ, Streubel B, Raffeld M, Jaffe ES, Pittaluga S (2011) Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases. Mod Pathol 24:355\u2013366. doi: 10.1038\/modpathol.2010.206","journal-title":"Mod Pathol"},{"key":"1858_CR59","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/PAS.0b013e3182049a9c","volume":"35","author":"C Visco","year":"2011","unstructured":"Visco C, Hoeller S, Malik JT, Xu-Monette ZY, Wiggins ML, Liu J, Sanger WG, Liu Z, Chang J, Ranheim EA, Gradowski JF, Serrano S, Wang HY, Liu Q, Dave S, Olsen B, Gascoyne RD, Campo E, Swerdlow SH, Chan WC, Tzankov A, Young KH (2011) Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component. Am J Surg Pathol 35:177\u2013189. doi: 10.1097\/PAS.0b013e3182049a9c","journal-title":"Am J Surg Pathol"},{"key":"1858_CR60","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MD.0b013e31829cce35","volume":"92","author":"ZS Wallace","year":"2013","unstructured":"Wallace ZS, Carruthers MN, Khosroshahi A, Carruthers R, Shinagare S, Stemmer-Rachamimov A, Deshpande V, Stone JH (2013) IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore) 92:206\u2013216. doi: 10.1097\/MD.0b013e31829cce35","journal-title":"Medicine (Baltimore)"},{"key":"1858_CR61","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.humpath.2012.02.009","volume":"43","author":"E Wang","year":"2012","unstructured":"Wang E, Stoecker M, Burchette J, Rehder C (2012) Follicular lymphoma with prominent Dutcher body formation: a pathologic study of 3 cases in comparison with nodal or splenic lymphoplasmacytic lymphoma and marginal zone lymphoma. Hum Pathol 43:2001\u20132011. doi: 10.1016\/j.humpath.2012.02.009","journal-title":"Hum Pathol"},{"key":"1858_CR62","doi-asserted-by":"crossref","unstructured":"Yamada S, Ishida Y, Matsuno A, Yamazaki K (2015) Primary diffuse large B-cell lymphomas of central nervous system exhibit remarkably high prevalence of oncogenic MYD88 and CD79B mutations. Leuk Lymphoma:1\u20135. doi: 10.3109\/10428194.2014.979413","DOI":"10.3109\/10428194.2014.979413"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-015-1858-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-015-1858-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-015-1858-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T18:17:24Z","timestamp":1718129844000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-015-1858-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,10]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["1858"],"URL":"https:\/\/doi.org\/10.1007\/s00428-015-1858-9","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,10]]}}}